Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
The independent source for health policy research, polling, and news.
7,161 - 7,180 of 15,455 Results
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
A Kaiser Health News analysis of federal inspection records shows that nursing home inspectors labeled mistakes in infection control as serious for only 161 of the 12,056 homes they have cited since 2014.
The House sought to eliminate the tax deduction, generally used by people with serious illnesses or those who need long-term care services but it was eventually restored in the final bill — and expanded.
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
Each hospital will have its payments reduced by 1 percent for the year.
HHS announces that 8.8 million people signed up for coverage through the federal insurance marketplace.
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss this week’s news, including health issues in the just-passed tax bill and a look back on the year in health policy.
Fire almost destroyed one of two acute care facilities in Ventura County — wiping out most of the region’s inpatient capacity. In California and nationally, such hospitals are strained by demand — and disasters.
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
Arizona is one of a few states that have declared the opioid epidemic a public health emergency. There's no uniformity in what that means from state to state, though, and even within Arizona, there's a wide divergence of opinion on how best to tackle the problem.
For those confronting the string of losses that accompany frailty or serious illness, experts offer salves.
Complaints are rising in California and other states about improper evictions and discharges. Advocates say some patients end up in cheap hotels, homeless or back in the hospital.
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn’t make those changes in the current tax bill.
Funding for the joint federal-state Children’s Health Insurance Program expired Oct. 1, and Congress has not yet agreed to a plan to continue the popular coverage.
It’s a regular part of the politically charged debate over health care. But the lines sometimes blur between rhetoric and how Canada’s system actually works.
American single-payer advocates want to emulate Canada’s system. But many Canadian experts say the U.S. first needs to address some basic questions.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss health issues in the emerging tax bill, including the likely repeal of fines for those who fail to obtain health insurance. They also talk about the end of “open enrollment” for 2018 individual health insurance coverage.
© 2026 KFF